ID   COLO 829BL
AC   CVCL_1999
SY   COLO-829BL; COLO-829-BL; COLO 829 BL; COLO829-BL; COLO829BL; Colorado 829BL
DR   CLO; CLO_0002564
DR   ATCC; CRL-1980
DR   BioSample; SAMN03471268
DR   Cell_Model_Passport; SIDM00908
DR   dbGAP; phs001839.v1.p1
DR   DepMap; ACH-002380
DR   EGA; EGAS00000000052
DR   Wikidata; Q54814158
RX   PubMed=14762065;
RX   PubMed=20016485;
RX   PubMed=20164919;
RX   PubMed=27094764;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Deep exome analysis.
CC   Omics: Genome sequenced.
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-1980
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 27,29
ST   D2S1338: 18,26
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 9,14
ST   Penta E: 7,12
ST   TH01: 10
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 24
//
RX   PubMed=14762065; DOI=10.1101/gr.2012304;
RA   Bignell G.R., Huang J., Greshock J., Watt S., Butler A.P., West S.,
RA   Grigorova M., Jones K.W., Wei W., Stratton M.R., Futreal P.A.,
RA   Weber B., Shapero M.H., Wooster R.;
RT   "High-resolution analysis of DNA copy number using oligonucleotide
RT   microarrays.";
RL   Genome Res. 14:287-295(2004).
//
RX   PubMed=20016485; DOI=10.1038/nature08658;
RA   Pleasance E.D., Cheetham R.K., Stephens P.J., McBride D.J.,
RA   Humphray S.J., Greenman C.D., Varela I., Lin M.-L., Ordonez G.R.,
RA   Bignell G.R., Ye K., Alipaz J.A., Bauer M.J., Beare D., Butler A.P.,
RA   Carter R.J., Chen L., Cox A.J., Edkins S., Kokko-Gonzales P.I.,
RA   Gormley N.A., Grocock R.J., Haudenschild C.D., Hims M.M., James T.,
RA   Jia M.-M., Kingsbury Z., Leroy C., Marshall J., Menzies A., Mudie L.J.,
RA   Ning Z.-M., Royce T., Schulz-Trieglaff O.B., Spiridou A., Stebbings L.A.,
RA   Szajkowski L., Teague J.W., Williamson D., Chin L., Ross M.T.,
RA   Campbell P.J., Bentley D.R., Futreal P.A., Stratton M.R.;
RT   "A comprehensive catalogue of somatic mutations from a human cancer
RT   genome.";
RL   Nature 463:191-196(2010).
//
RX   PubMed=20164919; DOI=10.1038/nature08768;
RA   Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S.,
RA   Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S.,
RA   Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T.,
RA   Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.;
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//
RX   PubMed=27094764; DOI=10.1038/srep24607;
RA   Craig D.W., Nasser S., Corbett R., Chan S.K., Murray L., Legendre C.,
RA   Tembe W., Adkins J., Kim N., Wong S.-M., Baker A., Enriquez D., Pond S.,
RA   Pleasance E.D., Mungall A.J., Moore R.A., McDaniel T., Ma Y.,
RA   Jones S.J.M., Marra M.A., Carpten J.D., Liang W.S.;
RT   "A somatic reference standard for cancer genome sequencing.";
RL   Sci. Rep. 6:24607-24607(2016).
//